Effect of hormone replacement therapy on vasomotor function of the coronary microcirculation in post-menopausal women with medically treated cardiovascular risk factors

European Heart Journal

Volumn 30, Issue 8, 2009, Pages 978-986

  Schindler, Thomas H ^a,b   Campisi, Roxana ^a   Dorsey, Deborah ^a   Prior, John O ^a   Olschewski, Manfred ^c   Sayre, James ^a   Schelbert, Heinrich R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cardiovascular disease prevention; Coronary circulation; Endothelium; Oestrogen; Positron emission tomography; Post menopausal women

Indexed keywords

ESTROGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; FOLLOW UP; HEART MUSCLE BLOOD FLOW; HORMONE SUBSTITUTION; HUMAN; HYPEREMIA; LONGITUDINAL STUDY; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

ADULT; AGED; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; COLD TEMPERATURE; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; EPIDEMIOLOGIC METHODS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HEMODYNAMICS; HUMANS; MICROCIRCULATION; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; POSTMENOPAUSE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VASOMOTOR SYSTEM;

EID: 65249177165     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp013     Document Type: Article

References (19)

1. Stramba-Badiale M, Fox KM, Priori SG, Collins P, Daly C, Graham I, Jonsson B, Schenck-Gustafsson K, Tendera M. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006;27:994-1005.
2. Mendelsohn ME, Karas RH. HRT and the young at heart. N Engl J Med 2007;356: 2639-2641.
3. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR. Hormone therapy to prevent disease and prolong life in postme-nopausal women. Ann Intern Med 1992;117:1016-1037.
4. Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 2006;166:357-365.
5. Sare GM, Gray LJ, Bath PM. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J 2008;29:2031-2041.
6. Lokkegaard E, Andreasen AH, Jacobsen RK, Nielsen LH, Agger C, Lidegaard O. Hormone therapy and risk of myocardial infarction: a national register study. Eur Heart J 2008;29:2660-2668.
7. Schindler TH, Zhang XL, Vincenti G, Mhiri L, Lerch R, Schelbert HR. Role of PET in the evaluation and understanding of coronary physiology. J Nucl Cardiol 2007; 14:589-603.
8. Campisi R, Nathan L, Pampaloni MH, Schoder H, Sayre JW, Chaudhuri G, Schelbert HR. Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration. Circulation 2002;105:425-430.
9. Schindler TH, Zhang XL, Prior JO, Cadenas J, Dahlbom M, Sayre J, Schelbert HR. Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET. Eur J Nucl Med Mol Imaging 2007;34:1178-1188.
10. Koh KK, Han SH, Shin MS, Ahn JY, Lee Y, Shin EK. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study. Eur Heart J 2005;26:1362-1368.
11. Duvernoy CS, Rattenhuber J, Seifert-Klauss V, Bengel F, Meyer C, Schwaiger M. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women. J Gend Specif Med 2001;4:21-27, 47.
12. Duvernoy C, Martin J, Briesmiester K, Bargardi A, Muzik O, Mosca L. Myocardial blood flow and flow reserve in response to hormone therapy in postmenopausal women with risk factors for coronary disease. J Clin Endocrinol Metab 2004;89: 2783-2788.
13. Peterson LR, Eyster D, Davila-Roman VG, Stephens AL, Schechtman KB, Herrero P, Gropler RJ. Short-term oral estrogen replacement therapy does not augment endothelium-independent myocardial perfusion in postmenopausal women. Am Heart J 2001;142:641-647.
14. Knuuti J, Kalliokoski R, Janatuinen T, Hannukainen J, Kalliokoski KK, Koskenvuo J, Lundt S. Effect of estradiol-drospirenone hormone treatment on myocardial per-fusion reserve in postmenopausal women with angina pectoris. Am J Cardiol 2007; 99:1648-1652.
15. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation 2001;104:735-740.
16. Laufs U, Endres M, Custodis F, Gertz K, Nickenig G, Liao JK, Bohm M. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation 2000;102:3104-3110.
17. Clarkson TB, Anthony MS, Williams JK, Honore EK, Cline JM. The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy. Proc Soc Exp Biol Med 1998;217:365-368.
18. Vitale C, Mercuro G, Cerquetani E, Marazzi G, Patrizi R, Pelliccia F, Volterrani M, Fini M, Collins P, Rosano GM. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 2008;28:348-352.
19. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297:1465-1477.